Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | SNDXSyndax Pharmaceuticals IncFY2025 · Dec |
|---|---|
| Revenue | $172.35M |
| Revenue, yoy | +627.8% |
| Net income | $285.42M |
| Net income, yoy | +10.5% |
| Net margin | -165.6% |
| Free cash flow | $323.17M |
| FCF margin | -187.5% |
| EPS, diluted | $3.29 |
Add another company.